Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis
Titel:
Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis
Auteur:
Quistrebert, Jocelyn Hässler, Signe Bachelet, Delphine Mbogning, Cyprien Musters, Anne Tak, Paul Peter Wijbrandts, Carla Ann Herenius, Marieke Bergstra, Sytske Anne Akdemir, Gülşah Johannesson, Martina Combe, Bernard Fautrel, Bruno Chollet-Martin, Sylvie Gleizes, Aude Donnellan, Naoimh Deisenhammer, Florian Davidson, Julie Hincelin-Mery, Agnès Dönnes, Pierre Fogdell-Hahn, Anna De Vries, Niek Huizinga, Tom Abugessaisa, Imad Saevarsdottir, Saedis Hacein-Bey-Abina, Salima Pallardy, Marc Broët, Philippe Mariette, Xavier